All4Cure
Seattle, Washington, 98136, United States
Location status: Recruiting
Location contact
Carl A Blau, MD
CONTACT
Kimberly A Burton, PhD
CONTACT
NCT Number: NCT03530826
All4Cure aims to accelerate learning about cancer by sharing medical information and research results from cancer patients with fellow cancer patients, oncologists, and scientists on the All4Cure website with the hope that together patients, clinicians and researchers can cure cancer faster.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Seattle, Washington, 98136, United States
Location status: Recruiting
Carl A Blau, MD
CONTACT
Kimberly A Burton, PhD
CONTACT
The core hypothesis tested by this study is that engaging researchers, clinicians and patients in an online knowledge sharing platform will enable patients to better understand cancer, better inform treatment decisions made by oncologists and accelerate cancer research. Leftover samples from patients with cancer (blood, bodily fluids and/or tissues collected for clinical purposes) will be obtained and sent for various types of analyses and results will be shared on the All4Cure website.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No Intervention
Time frame: 6 years
Profiles of pre- and post-treatment tumor tissue will be compared.
Contact information is provided by the study sponsor or research team.
Carl A Blau, MD
CONTACT
Kimberly A Burton, PhD
CONTACT
All4Cure
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724535
Cancer, Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT05754801
Cancer, Neoplasms
Hong Kong
View Trial DetailsNCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial DetailsNCT05350761
Cancer, Environment
Bethesda, Maryland, United States
View Trial Details